Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)

Shanghai Fosun Pharmaceutical (Group) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14,080	13,694	16,241	10,317	9,962	9,533
Trading Asset Securities	2,021	1,888	928.53	4,241	1,970	456.65
Cash & Short-Term Investments	16,101	15,582	17,170	14,558	11,932	9,990
Cash Growth	-7.04%	-9.25%	17.94%	22.01%	19.44%	9.03%
Accounts Receivable	8,847	8,457	8,172	6,474	5,436	5,053
Other Receivables	676.91	636.27	611.57	875.26	357.09	442.75
Receivables	9,524	9,093	8,783	7,538	5,793	5,496
Inventory	7,512	7,538	6,882	5,473	5,163	3,941
Other Current Assets	1,661	1,580	2,443	2,868	2,197	977.34
Total Current Assets	34,798	33,793	35,279	30,437	25,085	20,403
Property, Plant & Equipment	21,558	22,239	16,028	13,284	13,003	11,085
Long-Term Investments	26,148	25,012	25,549	23,920	23,771	23,021
Goodwill	10,880	10,852	10,337	9,400	8,677	9,014
Other Intangible Assets	13,278	13,482	12,471	10,276	8,670	7,916
Long-Term Accounts Receivable	85.31	83.01	91.66	77.4	-	-
Long-Term Deferred Tax Assets	660.09	624.47	442.57	265.59	244.94	196.09
Long-Term Deferred Charges	5,457	4,675	4,008	3,632	3,152	3,211
Other Long-Term Assets	2,476	2,512	2,836	2,014	894.88	1,085
Total Assets	115,538	113,470	107,164	93,306	83,686	76,120
Accounts Payable	6,526	6,160	6,284	5,064	3,289	2,397
Accrued Expenses	4,586	5,414	5,577	4,807	4,234	3,849
Short-Term Debt	17,317	14,728	11,932	10,629	7,916	6,358
Current Portion of Long-Term Debt	5,283	4,422	5,230	4,986	6,771	2,418
Current Portion of Leases	299.69	329.53	184.41	141.5	151.08	143.79
Current Income Taxes Payable	249.81	250.63	619.34	474.22	325.43	452.59
Current Unearned Revenue	1,082	1,200	1,545	1,154	1,020	511.22
Other Current Liabilities	2,058	1,253	1,928	2,063	1,165	1,304
Total Current Liabilities	37,402	33,758	33,298	29,318	24,872	17,434
Long-Term Debt	9,799	13,505	12,100	9,049	8,476	12,577
Long-Term Leases	1,958	2,050	744.99	648.36	627.29	410.19
Long-Term Unearned Revenue	988.39	959.18	986.85	751.82	603.91	640.35
Long-Term Deferred Tax Liabilities	3,407	3,445	3,363	3,130	2,853	2,994
Other Long-Term Liabilities	3,122	3,137	2,562	2,029	269.49	2,860
Total Liabilities	56,676	56,853	53,055	44,927	37,702	36,915
Common Stock	2,672	2,672	2,672	2,563	2,563	2,563
Additional Paid-In Capital	17,568	16,853	16,992	14,041	15,133	12,144
Retained Earnings	28,001	27,501	26,170	23,858	20,234	17,650
Treasury Stock	-74.26	-41.93	-53.25	-	-	-
Comprensive Income & Other	-1,200	-1,300	-1,198	-1,266	-933.58	-467.99
Total Common Equity	46,967	45,685	44,582	39,196	36,996	31,888
Minority Interest	11,895	10,931	9,526	9,184	8,989	7,316
Shareholders' Equity	58,862	56,616	54,109	48,380	45,984	39,204
Total Liabilities & Equity	115,538	113,470	107,164	93,306	83,686	76,120
Total Debt	34,657	35,035	30,191	25,454	23,941	21,908
Net Cash (Debt)	-18,556	-19,453	-13,021	-10,896	-12,009	-11,918
Net Cash Per Share	-6.95	-7.29	-4.99	-4.25	-4.69	-4.65
Filing Date Shares Outstanding	2,671	2,672	2,672	2,563	2,563	2,563
Total Common Shares Outstanding	2,671	2,672	2,672	2,563	2,563	2,563
Working Capital	-2,604	34.99	1,981	1,118	212.45	2,970
Book Value Per Share	17.58	17.10	16.68	15.29	14.44	12.44
Tangible Book Value	22,809	21,351	21,774	19,519	19,649	14,958
Tangible Book Value Per Share	8.54	7.99	8.15	7.62	7.67	5.84
Land	936.08	951.74	201.31	203.68	196.58	188.04
Buildings	10,623	11,471	7,733	6,605	6,359	5,796
Machinery	14,252	14,026	10,700	9,197	8,270	7,368
Construction In Progress	4,888	4,938	4,897	3,618	4,122	3,150

Source: S&P Capital IQ. Standard template. Financial Sources.